Diane Von Ah, Ph.D., R.N.
1111 Middle Drive
Indianapolis, IN 46202
Phone: (317) 278-2827
Fax: (317) 278-1856
Research Program Membership
IU School of Nursing
Diane Von Ah is an Assistant Professor at the School of Nursing at Indiana University, Indianapolis, Indiana. Dr. Von Ah completed a post-doctoral fellowship in behavioral oncology at Indiana University, her doctorate in nursing from the University of Alabama at Birmingham in 2003, and her masters in nursing (1996) and bachelors degree in nursing (1987) from the University of Iowa.
Dr. Von Ah's research focuses on cancer survivorship, including cancer symptom management and quality of life of cancer survivors. Specifically, Dr. Von Ah's research focuses on the problem of cognitive dysfunction in breast cancer survivors. Her work incorporates three main foci aimed at alleviating cognitive dysfunction in cancer patients including: description of incidence and impact, understanding of physiological mechanisms, and effects of behavioral and pharmacological interventions. Dr. Von Ah's research in cancer symptom management has been funded by the Susan G. Komen Foundation Birmingham Affiliate, Sigma Theta Tau International Nu Chapter, Oncology Nursing Society Foundation and the Indiana University General Clinical Research Center. This innovative work represents one of the first studies to evaluate the impact of cognitive dysfunction on quality of life outcomes in breast cancer survivors, the first study to evaluate the role of serotonin in cognitive dysfunction in persons affected by cancer, and one of a limited set of nursing studies that incorporate genetic predictors of outcomes. Dr. Von Ah has been recognized nationally for her research. She was named the 2008 Midwest Nursing Research Society Women's Health Research Section New Investigator and was most recently selected by the Robert Wood Johnson Foundation as a Nurse Faculty Scholar. Dr. Von Ah's primary research goals will be to (1) describe the incidence and impact of cognitive dysfunction in cancer patients and survivors; (2) identify correlated symptoms or symptom clusters which include cognitive dysfunction in cancer survivors; (3) identify underlying physiological mechanisms of cognitive dysfunction; and (4) test the efficacy of promising behavioral and pharmacological interventions to alleviate cognitive dysfunction in cancer survivors.
Post-doctoral Fellowship - Indiana University, Indianapolis, IN 2005-2008
Ph.D. - University of Alabama at Birmingham, Alabama 1999-2003
M.S.N. - University of Iowa, Iowa City, Iowa 1992-1996
B.S.N. - University of Iowa, Iowa City, Iowa 1983-1987